Next Article in Journal
Adjuvant FOLFIRINOX in Patients with Resectable Pancreatic Cancer Is Effective but Rarely Feasible in Real Life: Is Neoadjuvant FOLFIRINOX a Better Option?
Next Article in Special Issue
Radiomic Analysis of Intrahepatic Cholangiocarcinoma: Non-Invasive Prediction of Pathology Data: A Multicenter Study to Develop a Clinical–Radiomic Model
Previous Article in Journal
Third-Line Palliative Systemic Therapy for Advanced Biliary Tract Cancer: Multicentre Review of Patterns of Care and Outcomes
Previous Article in Special Issue
Targeting FGFRs Using PD173074 as a Novel Therapeutic Strategy in Cholangiocarcinoma
 
 
Systematic Review

Article Versions Notes

Cancers 2023, 15(11), 3048; https://doi.org/10.3390/cancers15113048
Action Date Notes Link
article html file updated 11 September 2025 22:15 CEST Update https://www.mdpi.com/2072-6694/15/11/3048/html
article html file updated 6 September 2025 09:59 CEST Update -
article html file updated 20 June 2023 20:32 CEST Update -
article html file updated 3 June 2023 14:26 CEST Update -
article pdf uploaded. 3 June 2023 14:25 CEST Updated version of record https://www.mdpi.com/2072-6694/15/11/3048/pdf
article xml uploaded. 3 June 2023 14:25 CEST Update https://www.mdpi.com/2072-6694/15/11/3048/xml
article xml file uploaded 3 June 2023 14:25 CEST Update -
article html file updated 3 June 2023 13:25 CEST Original file -
article pdf uploaded. 3 June 2023 13:24 CEST Version of Record -
article xml uploaded. 3 June 2023 13:24 CEST Update -
article xml file uploaded 3 June 2023 13:24 CEST Original file -
Back to TopTop